Pirin: a potential novel therapeutic target for castration‐resistant prostate cancer regulated by miR‐455‐5p

Androgen deprivation therapy is frequently used to treat prostate cancer (PCa), but resistance can occur, a condition known as castration‐resistant prostate cancer (CRPC). Thus, novel approaches for identification of CRPC are important for designing effective PCa treatments. Analysis of microRNA (mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Arai, Takayuki, Kojima, Satoko, Yamada, Yasutaka, Sugawara, Sho, Kato, Mayuko, Yamazaki, Kazuto, Naya, Yukio, Ichikawa, Tomohiko, Seki, Naohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360383/
https://www.ncbi.nlm.nih.gov/pubmed/30444038
http://dx.doi.org/10.1002/1878-0261.12405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360383/
https://www.ncbi.nlm.nih.gov/pubmed/30444038
http://dx.doi.org/10.1002/1878-0261.12405

Ejemplares similares